Proteomic Profiling of the Serum of Patients with COVID-19 Reveals Key Factors in the Path to Clinical Improvement
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Zhong W, Altay O, Arif M, Edfors F, Doganay L, Mardinoglu A
. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms. EBioMedicine. 2021; 74:103723.
PMC: 8626206.
DOI: 10.1016/j.ebiom.2021.103723.
View
2.
Java A, Apicelli A, Liszewski M, Coler-Reilly A, Atkinson J, Kim A
. The complement system in COVID-19: friend and foe?. JCI Insight. 2020; 5(15).
PMC: 7455060.
DOI: 10.1172/jci.insight.140711.
View
3.
Kim A, Wu X, Atkinson J
. The beneficial and pathogenic roles of complement in COVID-19. Cleve Clin J Med. 2020; .
PMC: 8079550.
DOI: 10.3949/ccjm.87a.ccc065.
View
4.
DAlessandro A, Thomas T, Dzieciatkowska M, Hill R, Francis R, Hudson K
. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level. J Proteome Res. 2020; 19(11):4417-4427.
PMC: 7640953.
DOI: 10.1021/acs.jproteome.0c00365.
View
5.
Chawade A, Alexandersson E, Levander F
. Normalyzer: a tool for rapid evaluation of normalization methods for omics data sets. J Proteome Res. 2014; 13(6):3114-20.
PMC: 4053077.
DOI: 10.1021/pr401264n.
View